Global 3D Bioprinting Market size- Industry Trends & Outlook
Global 3D Bioprinting Market Overview
3D Bioprinting is an application of 3D printers in the medical field and involves 3D printing of natural tissues and organs by layering living cells. Its process passes through three stages viz., pre-bioprinting, bioprinting, and post-bioprinting. The output construct of the 3D Bioprinting is also preserved for R & D purposes. It is used to develop natural look-alike organ and tissue constructs which are again used for drug screening, tissue engineering & regenerative medicine, and tissue transplantation. The enterprises use innovative approaches and a combination of new materials for 3D printing. They engage in alliances, agreements, and collaborations with diverse market players besides product innovation and approvals to maintain or grow their share in the market.
Global 3D Bioprinting Market Outlook and Trends
Demand for High Throughput Models of Tissue
The drug research and development processes need high throughput models of tissue, and it leads to more demand for 3D Bioprinting for assuring effective regenerative medication. It assists in testing the efficacy of the drugs under study so that they closely imitate the native tissue. Due to its high utility in drug development and tissue implantation, the 3D Bioprinting Market holds bright prospects for the future.
3D Bioprinting technology has found increasing acceptance in the medical field. It has changed the diagnosis and treatment of various physical conditions through the fabrication of artificial tissues and organs. Bioprinting companies continuously work on the advanced application of 3D Bioprinting in drug development, tissue transplantation, and regenerative medicine for ensuring customized medical treatment, better patient care, and as a substitute to organ transplantation. Significant technological advancements have been noticed for skin tissue development, cancer therapeutics, liver modeling, and bone, and cartilage development. They provide an edge to the market player, securing its market share.
Shortage of Skilled Professionals
The Global 3D Bioprinting market holds tremendous potential in
the medical field, but its growth is restrained by the scarcity of skilled
professionals to operate technologically advanced 3D Bioprinters. To build such
capability poses a challenge to this market.
The Global 3D Bioprinting market is segmented into three
categories based on Component, Material and Application. Component-based
segments include Micro Extrusion, Inkjet and Laser; while Material based
segments include Hydrogel and Living Cells. The Application based segment is
again divided into Skin and Drug Research.
In Material-based segment, Living cells segment accounts for the
largest share in the market due to its extensive use in regenerative medicines
and stem cells research and increased funding support. It is expected to
continue its dominance during the projected period also. In the Application
based segment, skin bio printing segment dominates the market in comparison to
others, and it is likely to register the highest CAGR during the forecast
North America retained the largest share in the market in 2019
due to growing state expenditure on health care, technological developments and
robust healthcare infrastructure. It is anticipated to maintain its share and
momentum in the market during the forecast period. However, Asia Pacific Market
is expected to grow at the highest CAGR during this period due to increasing R
& D activities including stem cell research, growing need for organ
transplants and increasing initiatives by market players. China and India offer
tremendous growth opportunities for this market because of growing state
support, rise in cosmetic surgeries, liberal regulations and little data
The major players in the market are EnvisionTEC (Germany), Organovo Holdings Inc. (US), Cyfuse
Biomedical KK (Japan), BioBot (US), Nano3D Biosciences, Inc.(US), Aspect
Biosystems Ltd.(Canada), 3Dynamic Systems Ltd (US), CELLINK (US), Materialise
NV (UK), Vivax Bio, LLC (US) and others.
February 12, 2020: Researchers at Northwestern University prints tissues that
mimic human bile duct by using EnvisionTEC 3D Bio-Plotter. Bile duct plays a
vital role in digestion, and its cancer leaves fewer survival chances.
October 23, 2019: Cyfuse Biomedical KK announces business alliance with Marubeni
Corporation regarding Global Expansion of a new Bio 3D Printer S-PIKE developed
and commercialized by Cyfuse.
Scope of the Report
Historical data – 2016-2019
Base Year – 2019
2020 – 2026
Revenue in USD Million
U.S, Canada, Germany, UK, France,
Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, South Korea
UAE, South Africa, Saudi Arabia.
By Component, By Material, By Application, By End-user
(Germany), Organovo Holdings Inc. (US), Cyfuse Biomedical KK (Japan), BioBot
(US), Nano3D Biosciences, Inc.(US), Aspect Biosystems Ltd.(Canada), 3Dynamic
Systems Ltd (US), CELLINK (US), Materialise NV (UK), Vivax Bio, LLC (US).
Ø Living Cells
Ø North America
Ø Asia Pacific
Ø Latin America
Ø Middle East & Africa
The objective of the Study:
Ø To analyze and estimate the Global 3D Bioprinting Market size, in terms of value.
Ø To examine the market segmentation carefully and estimate the
market size, in terms of value, based on the region by segmenting the Global 3D Bioprinting Market into five regions, namely, North America, Europe, Asia Pacific,
Rest of the World and their leading countries.
Ø To outline, categorize, and project the Global 3D Bioprinting Market based on the Type, Application, End-User, and Region.
Ø To examine competitive developments in applications, technology, and network, content, and live streaming within the Global 3D Bioprinting Market.
Ø To highlight market dynamics such as drivers, restraints,
opportunities, and challenges and their impact.
Ø To provide a detailed competitive landscape, including major
players, their strategic profiles, and market shares.
Business Questions Answered by the Report:
Ø How will the market drivers, restraints, and opportunities
affect the market dynamics?
Ø What will be the market size in terms of value and volume and
market statistics with a detailed classification?
Ø Which segment dominates the market or region, and which one will
be the fastest-growing, and why?
Ø Who are the key players in the market, and what is their share?
Ø What is the strategy adopted by key players, and how does it
affect the existing and new players?
Customization Scope for the Client:
Client satisfaction is our first and last priority, and that is
why BlueWeave Consulting offers customization as per client’s specific needs.
The following customization options are available for the report:
Ø Additional Company Information
Ø Detail Analysis of five additional companies
Ø Additional country analysis
Ø Detailed segment analysis